Neovacs S.A. (EPA:ALNEV)
0.0017
-0.0002 (-10.53%)
Feb 12, 2026, 5:06 PM CET
Neovacs Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 0.04 | 0.44 | 0.89 | 0.04 | 16.25 | 10.07 |
Short-Term Investments | - | 0 | - | 6.72 | 16.84 | - |
Cash & Short-Term Investments | 0.04 | 0.44 | 0.89 | 6.76 | 33.09 | 10.07 |
Cash Growth | -83.37% | -50.91% | -86.87% | -79.57% | 228.45% | 675.67% |
Accounts Receivable | 0.37 | 0.31 | 0.57 | 0.01 | 0.01 | 0.08 |
Other Receivables | 2.2 | 1.65 | 2.21 | 1.8 | 1.59 | 2.76 |
Receivables | 2.57 | 1.95 | 2.78 | 1.81 | 1.6 | 2.83 |
Prepaid Expenses | 0.09 | 0.08 | 0.07 | 0.49 | 0.05 | 0.16 |
Other Current Assets | -0 | 0.01 | 0.08 | 0.01 | 0.04 | 0.03 |
Total Current Assets | 2.7 | 2.48 | 3.81 | 9.07 | 34.78 | 13.1 |
Property, Plant & Equipment | 0.33 | 0.41 | 0.53 | 0.51 | 0.51 | 0.26 |
Long-Term Investments | 19.47 | 18.68 | 41.49 | 42.33 | 13.27 | 0.18 |
Other Intangible Assets | 0 | 0 | 0 | 0 | 0 | - |
Other Long-Term Assets | 0.58 | 0.5 | 3.83 | 0.89 | 0 | 0 |
Total Assets | 23.07 | 22.07 | 52.56 | 55.29 | 48.55 | 13.53 |
Accounts Payable | 2.64 | 2.28 | 1.98 | 1.93 | 1.32 | 1.29 |
Accrued Expenses | 0.05 | 1.04 | 0.02 | 0.04 | 0.56 | 0.28 |
Short-Term Debt | 0 | 0 | 0 | 0 | 0.01 | 0 |
Current Portion of Long-Term Debt | 0.17 | 0.23 | 0.65 | - | - | - |
Current Income Taxes Payable | 1.14 | 0.29 | 0.98 | 1.4 | 0.32 | 0.47 |
Other Current Liabilities | 0.01 | 0.01 | 0.08 | 0.01 | 0.02 | 0.08 |
Total Current Liabilities | 4.01 | 3.84 | 3.71 | 3.38 | 2.22 | 2.11 |
Long-Term Debt | - | - | - | 1.2 | 1.03 | 0.39 |
Other Long-Term Liabilities | 0.17 | 0.17 | 0.01 | 0.55 | 1.4 | 0.01 |
Total Liabilities | 4.18 | 4.01 | 3.72 | 5.13 | 4.65 | 2.51 |
Common Stock | 0.48 | 0.17 | 0.35 | 0.12 | 1.99 | 0.68 |
Additional Paid-In Capital | 78.91 | 77.57 | 141.78 | 139.67 | 135.12 | 103.3 |
Retained Earnings | -60.49 | -60.34 | -94.6 | -89.63 | -93.22 | -93.96 |
Comprehensive Income & Other | - | 0.65 | 1.31 | - | - | 1 |
Shareholders' Equity | 18.89 | 18.06 | 48.84 | 50.17 | 43.9 | 11.02 |
Total Liabilities & Equity | 23.07 | 22.07 | 52.56 | 55.29 | 48.55 | 13.53 |
Total Debt | 0.17 | 0.23 | 0.65 | 1.2 | 1.03 | 0.39 |
Net Cash (Debt) | -0.13 | 0.21 | 0.24 | 5.55 | 32.06 | 9.68 |
Net Cash Growth | - | -13.29% | -95.74% | -82.67% | 231.12% | 684.25% |
Net Cash Per Share | -0.28 | - | - | 0.02 | 16.10 | 0.01 |
Working Capital | -1.31 | -1.37 | 0.1 | 5.68 | 32.55 | 10.99 |
Tangible Book Value | 18.89 | 18.06 | 48.84 | 50.16 | 43.9 | 11.02 |
Machinery | 1.41 | 1.41 | 1.33 | 1.25 | 1.12 | 0.67 |
Construction In Progress | - | - | - | - | - | 0.13 |
Order Backlog | - | 0.6 | 0.74 | 0.73 | 0.45 | 0.27 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.